These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 16002531)

  • 1. The new biology of aldosterone.
    Connell JM; Davies E
    J Endocrinol; 2005 Jul; 186(1):1-20. PubMed ID: 16002531
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypertension and the expanding role of aldosterone.
    Mackenzie SM; Connell J
    Curr Hypertens Rep; 2006 Jun; 8(3):255-61. PubMed ID: 17147925
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Endothelial action of aldosterone--therapeutic implications from basic and clinical research].
    Drelicharz L; Mikita J; Chabielska E; Chłopicki S
    Kardiol Pol; 2005 Oct; 63(4 Suppl 2):S409-19. PubMed ID: 20527396
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aldosterone and mineralocorticoid receptors in the cardiovascular system.
    Funder JW
    Prog Cardiovasc Dis; 2010; 52(5):393-400. PubMed ID: 20226957
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mineralocorticoid receptors and pathophysiological roles for aldosterone in the cardiovascular system.
    Young MJ; Funder JW
    J Hypertens; 2002 Aug; 20(8):1465-8. PubMed ID: 12172301
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genomic and rapid effects of aldosterone: what we know and do not know thus far.
    Hermidorff MM; de Assis LV; Isoldi MC
    Heart Fail Rev; 2017 Jan; 22(1):65-89. PubMed ID: 27942913
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of mineralocorticoid receptor antagonists in cardiovascular disease.
    Ferrario CM; Schiffrin EL
    Circ Res; 2015 Jan; 116(1):206-13. PubMed ID: 25552697
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vascular Consequences of Aldosterone Excess and Mineralocorticoid Receptor Antagonism.
    Chrissobolis S
    Curr Hypertens Rev; 2017; 13(1):46-56. PubMed ID: 28245785
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aldosterone and aldosterone antagonism in systemic hypertension.
    Frishman WH; Stier CT
    Curr Hypertens Rep; 2004 Jun; 6(3):195-200. PubMed ID: 15128471
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aldosterone and its mechanism of action: more questions than answers.
    Fuller PJ
    Aust N Z J Med; 1995 Dec; 25(6):800-7. PubMed ID: 8770356
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Endocrinology of aldosterone].
    Ronconi V; Giacchetti G; Boscaro M
    Ital Heart J; 2005 May; 6 Suppl 1():5S-15S. PubMed ID: 15945295
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aldosterone as a mediator in cardiovascular injury.
    Stier CT; Chander PN; Rocha R
    Cardiol Rev; 2002; 10(2):97-107. PubMed ID: 11895576
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel Insights into the Crosstalk between Mineralocorticoid Receptor and G Protein-Coupled Receptors in Heart Adverse Remodeling and Disease.
    Parker BM; Wertz SL; Pollard CM; Desimine VL; Maning J; McCrink KA; Lymperopoulos A
    Int J Mol Sci; 2018 Nov; 19(12):. PubMed ID: 30486399
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aldosterone target organ protection by eplerenone.
    Rudolph AE; Rocha R; McMahon EG
    Mol Cell Endocrinol; 2004 Mar; 217(1-2):229-38. PubMed ID: 15134822
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New Sides of Aldosterone Action in Cardiovascular System as Potential Targets for Therapeutic Intervention.
    Kolodziejczyk P; Gromotowicz-Poplawska A; Aleksiejczuk M; Chabielska E; Tutka P; Miltyk W
    Curr Drug Targets; 2018; 19(16):1968-1979. PubMed ID: 29577853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adverse Effects of Aldosterone: Beyond Blood Pressure.
    Brown JM
    J Am Heart Assoc; 2024 Apr; 13(7):e030142. PubMed ID: 38497438
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Aldosterone: the mechanisms of molecular action].
    Logvinenko NS
    Ross Fiziol Zh Im I M Sechenova; 2007 Jul; 93(7):746-61. PubMed ID: 17912848
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nontraditional aspects of aldosterone physiology.
    Ngarmukos C; Grekin RJ
    Am J Physiol Endocrinol Metab; 2001 Dec; 281(6):E1122-7. PubMed ID: 11701424
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aldosterone receptor antagonists: current perspectives and therapies.
    Guichard JL; Clark D; Calhoun DA; Ahmed MI
    Vasc Health Risk Manag; 2013; 9():321-31. PubMed ID: 23836977
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aldosterone and specific aldosterone receptor antagonists in hypertension and cardiovascular disease.
    Bravo EL
    Curr Hypertens Rep; 2003 Apr; 5(2):122-5. PubMed ID: 12642011
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.